Eczematous eruption during anti-interleukin 17 treatment of psoriasis: an emerging condition

被引：54
|
作者：
Napolitano, M. [1 ]
Megna, M. [2 ]
Fabbrocini, G. [2 ]
Nistico, S. P. [3 ]
Balato, N. [2 ]
Dastoli, S. [3 ]
Patruno, C. [3 ]
机构：
[1] Univ Molise, Dept Med & Hlth Sci Vincenzo Tiberio, Campobasso, Italy
[2] Univ Naples Federico II, Dept Clin Med & Surg, Sect Dermatol, Naples, Italy
[3] Magna Graecia Univ Catanzaro, Dept Hlth Sci, Catanzaro, Italy
来源：
BRITISH JOURNAL OF DERMATOLOGY | 2019年 / 181卷 / 03期
关键词：
DRUG ERUPTION; DISEASES;
D O I：
10.1111/bjd.17779
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：604 / 606
页数：3
相关论文
共 50 条
  • [41] Brodalumab, an Anti-Interleukin-17-Receptor Antibody for Psoriasis
    Papp, Kim A.
    Leonardi, Craig
    Menter, Alan
    Ortonne, Jean-Paul
    Krueger, James G.
    Kricorian, Gregory
    Aras, Girish
    Li, Juan
    Russell, Chris B.
    Thompson, Elizabeth H. Z.
    Baumgartner, Scott
    NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (13): : 1181 - 1189
  • [42] Anti-Interleukin-17 Monoclonal Antibody Ixekizumab in Psoriasis
    Wu, Jashin J.
    NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (03): : 274 - 275
  • [43] Improvement of HbA1c during treatment with humanised anti-interleukin 6 receptor antibody, tocilizumab
    Ogata, Atsushi
    Morishima, Atsuyoshi
    Hirano, Toru
    Hishitani, Yoshihiro
    Hagihara, Keisuke
    Shima, Yoshihito
    Narazaki, Masashi
    Tanaka, Toshio
    ANNALS OF THE RHEUMATIC DISEASES, 2011, 70 (06) : 1164 - 1165
  • [44] Anti-interleukin 1 treatment in secondary renal amyloidosis associated with autoinflammatory diseases
    R Topaloglu
    ED Batu
    D Orhan
    S Ozen
    N Besbas
    Pediatric Rheumatology, 13 (Suppl 1)
  • [45] Anti-Interleukin 23 Biologic Are Mostly Effective and Safe in Psoriatic Patients Who Failed Anti-Interleukin 17. A Real-Life, Retrospective 52-Week Experience
    Arroyo-Andres, J.
    Falkenhain-Lopez, D.
    Agud-Dios, M.
    Rivera-Diaz, R.
    ACTAS DERMO-SIFILIOGRAFICAS, 2023, 114 (04): : T363 - T365
  • [46] Anti-Interleukin 1 Treatment for Patients with Familial Mediterranean Fever Resistant to Colchicine
    Ozen, Seza
    Bilginer, Yelda
    Ayaz, Nuray Aktay
    Calguneri, Meral
    JOURNAL OF RHEUMATOLOGY, 2011, 38 (03) : 516 - 518
  • [47] Anti-interleukin 33 treatment alleviates psoriatic dermatitis in mice induced imiquimod
    Fu, Dandan
    Zheng, Shuting
    Li, Jialin
    Hu, Hua
    Wang, Qingqing
    Fu, Xiuyu
    Li, Min
    Yan, Dong
    Yang, Zishan
    Tian, Zhongwei
    Song, Xiangfeng
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2023, 121
  • [48] Anti-interleukin 6 receptor therapy as rescue treatment for giant cell arteritis
    Beyer, Christian
    Axmann, Roland
    Sahinbegovic, Enijad
    Distler, Joerg H.
    Manger, Bernhard
    Schett, Georg
    Zwerina, Jochen
    ANNALS OF THE RHEUMATIC DISEASES, 2011, 70 (10) : 1874 - 1875
  • [49] Effects of anti-interleukin 6 on inflammatory responses during murine septic peritonitis
    vanderPoll, T
    Keogh, CV
    Helfgott, D
    Berman, L
    Buurman, WA
    Lowry, SF
    JOURNAL OF ENDOTOXIN RESEARCH, 1996, 3 (06): : 463 - 470
  • [50] PReS-FINAL-1005: Hypertransaminasemia in systemic juvenile idiopathic arthritis during anti-interleukin 1 treatment
    MI Gonzalez Fernandez
    R Bou
    R Silvia
    E Iglesias
    J Sánchez
    V Torrente
    J Antón
    Pediatric Rheumatology, 11 (Suppl 2)
12345